These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32172924)

  • 1. Prurigo nodularis: New treatments on the horizon.
    Yosipovitch G
    J Am Acad Dermatol; 2020 Apr; 82(4):1035-1036. PubMed ID: 32172924
    [No Abstract]   [Full Text] [Related]  

  • 2. Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.
    Pezzolo E; Gambardella A; Guanti M; Bianchelli T; Bertoldi A; Giacchetti A; Donini M; Argenziano G; Naldi L
    J Am Acad Dermatol; 2023 Aug; 89(2):430-432. PubMed ID: 37150301
    [No Abstract]   [Full Text] [Related]  

  • 3. Dermal Periostin: A New Player in Itch of Prurigo Nodularis.
    Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Romanelli P; Yosipovitch G
    Acta Derm Venereol; 2021 Jan; 101(1):adv00375. PubMed ID: 33236123
    [No Abstract]   [Full Text] [Related]  

  • 4. Prurigo Nodularis: Review and Emerging Treatments.
    Leis M; Fleming P; Lynde CW
    Skin Therapy Lett; 2021 May; 26(3):5-8. PubMed ID: 34077168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding racial disparities in prurigo nodularis.
    Sutaria N; Semenov YR; Kwatra SG
    J Am Acad Dermatol; 2022 Sep; 87(3):e111-e112. PubMed ID: 35577228
    [No Abstract]   [Full Text] [Related]  

  • 6. Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.
    Serra-Baldrich E; Santamaría-Babí LF; Francisco Silvestre J
    Actas Dermosifiliogr; 2022; 113(7):674-684. PubMed ID: 35842249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Our experience with prurigo nodularis treated with dupilumab.
    Tilotta G; Pistone G; Caruso P; Gurreri R; Castelli E; Curiale S; Caputo V; Bongiorno MR
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e285-e287. PubMed ID: 33232536
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
    Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
    N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis.
    Gwillim EC; Nattkemper L; Yosipovitch G
    Acta Derm Venereol; 2021 Mar; 101(3):adv00424. PubMed ID: 33704503
    [No Abstract]   [Full Text] [Related]  

  • 10. Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study.
    Yi X; Cao Q; Peng C; Jia Q; Li J
    J Am Acad Dermatol; 2024 May; 90(5):1076-1078. PubMed ID: 38296194
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of Dupilimab With Severe Prurigo Nodularis That Responded Well to Abrocitinib.
    Vander Does A; Yosipovitch G
    Dermatitis; 2023; 34(6):567. PubMed ID: 36847309
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of 325 Patients with Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment.
    Gründel S; Pereira MP; Storck M; Osada N; Schneider G; Ständer S; Zeidler C
    Acta Derm Venereol; 2020 Sep; 100(16):adv00269. PubMed ID: 32556359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of dupilumab in prurigo nodularis in elderly patient.
    Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
    Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.
    Ständer S; Ketz M; Kossack N; Akumo D; Pignot M; Gabriel S; Chavda R
    Acta Derm Venereol; 2020 Nov; 100(18):adv00309. PubMed ID: 33021323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Dupilumab in Pediatric Patient With Prurigo Nodularis-Like Atopic Dermatitis.
    Yiling Y; Ali K; Jiayang D; Qiu Y; Kai G; JinPeng S; Tianci X; Min C; Menghua L; Liming W
    Dermatitis; 2023; 34(2):162-163. PubMed ID: 36917530
    [No Abstract]   [Full Text] [Related]  

  • 16. Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.
    Yook HJ; Lee JH
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin.
    Tupker RA; Coenraads PJ; van der Meer JB
    Acta Derm Venereol; 1992 Nov; 72(6):463. PubMed ID: 1362846
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of tuberculosis in patients with prurigo nodularis: A multicenter cross-sectional study.
    Cornman HL; Kambala A; Chen S; Zhang J; Reddy SV; Kwatra SG
    J Am Acad Dermatol; 2023 Aug; 89(2):406-408. PubMed ID: 37062464
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neurohistological studies on the differential diagnosis of prurigo nodularis Hyde and of other forms of circumscribed lichenification].
    THIES W
    Arch Klin Exp Dermatol; 1955; 201(6):539-55. PubMed ID: 13303208
    [No Abstract]   [Full Text] [Related]  

  • 20. A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis.
    Zhang Z; Li S; Wang Y; Zhao J
    An Bras Dermatol; 2023; 98(4):440-448. PubMed ID: 36966024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.